Gov't Contracts Of The Month: Antibodies, Prototype Weapons

The Biden administration awarded pharmaceutical companies $3.2 billion for antibody treatments, inked a $237 million deal with Dynetics for a prototype launcher, and gave Boeing a potential $23 billion deal for...

Already a subscriber? Click here to view full article